头孢哌酮/舒巴坦治疗急性脑血管病并发肺部感染的疗效

Comparative Study on Therapeutic Effect of Cefoperazone/Sulbactam and Ciprofloxacin in Treatment of Pulmonary Infection Complicated by the acute Cerebral Blood Vessel Disease

目的 :比较头孢哌酮 /舒巴坦与环丙沙星治疗急性脑血管病并发肺部感染的疗效。方法 :急性脑血管病并发肺部感染 90例 ,分为 2组。头孢哌酮 /舒巴坦治疗组 4 2例 ,用量 3givdbid ,7～ 14d为一疗程 ;环丙沙星对照组 4 8例 ,用量 2 0 0mgivdbid ,7～ 14d为一疗程。结果 :治疗组与对照组有效率分别为 97.6 0 %和 72 .90 % ,细菌清除率为 90 .4 8%和 6 6 .6 7% ,两者均有统计学差异 (P <0 .0 1) ;不良反应发生率 ,治疗组 2 .38% ,对照组 2 .0 8%。结论 :头孢哌酮

Objective: To compare the therapeutic effect of cefoperazone/subactam and ciprofloxacin in the treatment of pulmonary infection complicated due due to the acute cerebral blood vessel disease.Method: 90 cases of pulmonary infection complicated by the acute cerebral blood vessel disease were divided into 2 groups: cefoperazone/sulbactam group 42 cases,cefoperazone/sulbactam 3.0 , ivd, bid, 7 14 days as one course of treatment; ciprofloxacin group, 48cases, ciprofloxacin 0.2 , ivd, bid, course of treatment as former.Result: The effective rates in two groups were 97.60% and 72.90% , respectively, and the bacterium eliminative rates were 90.84% and 66.67% respectively, there was a statistical difference ( P < 0.01 ), the side effect incidences were 2.38% and 2.08% , respecfively.Conclusion: Cefoperazone/Sulbactam is effective in the treatment of pulmonary infection complicated due to the acute cerebral blood vessel disease.